Your browser doesn't support javascript.
loading
Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.
Tamaki, Nobuharu; Tada, Toshifumi; Kurosaki, Masayuki; Yasui, Yutaka; Ochi, Hironori; Mashiba, Toshie; Sakamoto, Azusa; Marusawa, Hiroyuki; Narita, Ryoichi; Uchida, Yasushi; Akahane, Takehiro; Kondo, Masahiko; Mori, Nami; Takaki, Shintaro; Tsuji, Keiji; Kobashi, Haruhiko; Kusakabe, Atsunori; Furuta, Koichiro; Arai, Hirotaka; Nonogi, Michiko; Ogawa, Chikara; Sato, Takashi; Tamada, Takashi; Nakamura, Shinichiro; Hasebe, Chitomi; Tsuchiya, Kaoru; Izumi, Namiki.
Afiliación
  • Tamaki N; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
  • Tada T; Department of Internal Medicine, Himeji Red Cross Hospital, Hyogo, Japan.
  • Kurosaki M; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan. kurosakim@gmail.com.
  • Yasui Y; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
  • Ochi H; Center for Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Ehime, Japan.
  • Mashiba T; Center for Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Ehime, Japan.
  • Sakamoto A; Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan.
  • Marusawa H; Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan.
  • Narita R; Department of Gastroenterology, Oita Red Cross Hospital, Oita, Japan.
  • Uchida Y; Department of Gastroenterology, Matsue Red Cross Hospital, Shimane, Japan.
  • Akahane T; Department of Gastroenterology, Ishinomaki Red Cross Hospital, Miyagi, Japan.
  • Kondo M; Department of Gastroenterology, Otsu Red Cross Hospital, Shiga, Japan.
  • Mori N; Department of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
  • Takaki S; Department of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
  • Tsuji K; Department of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
  • Kobashi H; Department of Gastroenterology, Japanese Red Cross Okayama Hospital, Okayama, Japan.
  • Kusakabe A; Department of Gastroenterology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Aichi, Japan.
  • Furuta K; Department of Gastroenterology, Masuda Red Cross Hospital, Shimane, Japan.
  • Arai H; Department of Gastroenterology, Maebashi Red Cross Hospital, Gunma, Japan.
  • Nonogi M; Department of Gastroenterology, Tokushima Red Cross Hospital, Tokushima, Japan.
  • Ogawa C; Department of Gastroenterology and Hepatology, Takamatsu Red Cross Hospital, Kagawa, Japan.
  • Sato T; Department of Gastroenterology, Nasu Red Cross Hospital, Tochigi, Japan.
  • Tamada T; Department of Gastroenterology, Takatsuki Red Cross Hospital, Osaka, Japan.
  • Nakamura S; Department of Internal Medicine, Himeji Red Cross Hospital, Hyogo, Japan.
  • Hasebe C; Department of Gastroenterology, Japanese Red Cross Asahikawa Hospital, Hokkaido, Japan.
  • Tsuchiya K; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
  • Izumi N; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
Invest New Drugs ; 40(6): 1290-1297, 2022 12.
Article en En | MEDLINE | ID: mdl-36152108
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos